Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash, cash equivalents and restricted cash	$ 1,041,438	$ 945,587
Short-term investments	1,000	22,689
Accounts receivable, net of allowance of $8,419 and $7,259 at September 30, 2025 and December 31, 2024, respectively	286,379	314,165
Inventory	64,644	44,744
Prepaid expenses and other current assets, net	53,862	48,635
Total current assets	1,447,323	1,375,820
Property and equipment, net	206,496	162,046
Operating lease right-of-use assets	96,988	86,149
Other assets	70,675	36,720
Total assets	1,821,482	1,660,735
Current liabilities:
Accounts payable	46,499	34,922
Accrued compensation	77,439	62,114
Other accrued liabilities	215,951	146,893
Deferred revenue, current portion	21,786	19,754
Short-term debt financing	80,341	80,362
Total current liabilities	442,016	344,045
Deferred revenue, long-term portion and other liabilities	22,898	24,682
Operating lease liabilities, long-term portion	104,380	96,588
Total liabilities	569,294	465,315
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both September 30, 2025 and December 31, 2024; 137,533 and 132,646 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	14	12
Additional paid-in capital	4,075,641	3,763,614
Accumulated deficit	(2,823,280)	(2,567,862)
Accumulated other comprehensive loss	(187)	(344)
Total stockholders' equity	1,252,188	1,195,420
Total liabilities and stockholders' equity	$ 1,821,482	$ 1,660,735